Mathers Edward T Insider Trades

Insider Trading History

Track insider trading activity for Mathers Edward T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
Director
Holding Value $580k 12,500 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 12,500 shares
$30.91
$46.39
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $608k 35,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 35,000 shares
$13.45
$17.38
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.5M 14,168 shares
Last Trade
Mar 12, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$383k 4,199 shares
$91.15
$106.19
Korro Bio
Korro Bio KRRO
10% owner
Holding Value $17.8M 1,297,893 shares
Last Trade
Mar 10, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.17M 450,045 shares
$11.48
$13.71
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $1.06M 9,969 shares
Last Trade
Mar 02, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$399k 4,198 shares
$94.94
$106.19
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $16.1M 2,384,873 shares
Last Trade
Oct 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.09k 458 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $16.1M 2,385,055 shares
Last Trade
Oct 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.09M 310,213 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $15.3M 2,261,870 shares
Last Trade
Oct 02, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$16.6M 2,453,520 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$4.1M 607,536 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $15.3M 2,260,970 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.5k 3,635 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $1.26M 186,128 shares
Last Trade
Oct 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 310,213 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.52M 225,000 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.68M 248,170 shares
$6.75
$6.75
Senti Biosciences
Senti Biosciences SNTI
Director
Holding Value $20.3k 21,950 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45k 21,950 shares
$2.05
$0.92
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $747k 7,037 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 7,037 shares
$63.66
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $743k 7,000 shares
Last Trade
Jun 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$106.19
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals RYTM
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$246k 4,000 shares
$61.48
$106.19
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $782k 45,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 45,000 shares
$6.25
$17.38
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
10% owner
Holding Value $742k 16,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 16,000 shares
$11.86
$46.39
Senti Biosciences
Senti Biosciences SNTI
Director
Holding Value $40.6k 43,900 shares
Last Trade
Mar 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$155k 43,900 shares
$3.52
$0.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up